8-K: Current report filing
Published on August 13, 2004
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): August 13, 2004
Access Pharmaceuticals, Inc.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-9314 83-0221517
- ------------------------ ------------------------ -------------------
(State of Incorporation) (Commission File Number) (I.R.S. Employer
Identification No.)
2600 Stemmons Freeway, Suite 176, Dallas, Texas 75207
----------------------------------------------- ---------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (214) 905-5100
--------------
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
------------------------------------------------------------------
(c) Exhibits
--------
99.1 Access Pharmaceuticals, Inc. Press Release, dated August 13, 2004.
Item 12. Disclosure of Results of Operations and Financial Condition.
------------------------------------------------------------
Access Pharmaceuticals, Inc. issued a press release on August 13, 2004, a
copy of which is attached as Exhibit 99.1 to this report and incorporated
herein by this reference, in which it announced its financial results for
the second quarter and six months ended June 30, 2004. This information
shall not be deemed to be "filed" for the purposes of Section 18 of the
Securities Exchange Act of 1934 and shall not be deemed to be
incorporated by reference in any filing under the Securities Act of 1933.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Access Pharmaceuticals, Inc.
(Registrant)
By: /s/ Stephen B. Thompson
------------------
Stephen B. Thompson
Vice President and
Chief Financial Officer
Dated August 13, 2004
3
EXHIBIT INDEX
Exhibit
Number Description
- ------- ------------
99.1 Press Release, date August 13, 2004
4